Takeda Pharmaceutical Co., Ltd. (TKPHF)
28.87
+0.26
(+0.92%)
USD |
OTCM |
Dec 11, 16:00
Takeda Pharmaceutical EPS Diluted (Quarterly): -0.0507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.53M |
| Revenue (Quarterly) | 7.546B |
| Total Expenses (Quarterly) | 7.626B |
| Enterprise Value | 72.45B |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -1.05% |
| Earnings Yield | 0.55% |
| Operating Earnings Yield | 7.12% |
| Normalized Earnings Yield | 1.293 |